Daily Archives: January 23, 2023
AHA Statement | Cancer therapy-related hypertension
23 Jan, 2023 | 13:46h | UTCTop Things to Know: Cancer Therapy-Related HTN – American Heart Association
Executive Summary | Guidelines for the diagnosis and management of pediatric acute respiratory distress syndrome
23 Jan, 2023 | 13:45h | UTC
M-A | Mean arterial pressure targets and patient-important outcomes in critically ill adults
23 Jan, 2023 | 13:41h | UTCMean Arterial Pressure Targets and Patient-Important Outcomes in Critically Ill Adults: A Systematic Review and Meta-Analysis of Randomized Trials – Critical Care Medicine (free for a limited period)
RCT | Effects of a web-guided system for self-treatment of recurrent benign paroxysmal positional vertigo
23 Jan, 2023 | 13:43h | UTCEffect of Self-treatment of Recurrent Benign Paroxysmal Positional Vertigo: A Randomized Clinical Trial – JAMA Neurology (free for a limited period)
Related Video: Web-Guided Canalith Reposition Maneuver – JAMA
Commentary: Web-Based System Works Well for Diagnosis, Treatment of Recurrent Vertigo – HealthDay
Commentary on Twitter
Patients may benefit from treating benign paroxysmal positional vertigo themselves using a web-guided system. https://t.co/9Hjwb0XGnl
— JAMA Neurology (@JAMANeuro) January 20, 2023
RCT | Intranasal mometasone furoate and saline are similarly effective for sleep-disordered breathing in children
23 Jan, 2023 | 13:39h | UTCEffectiveness of Intranasal Mometasone Furoate vs Saline for Sleep-Disordered Breathing in Children: A Randomized Clinical Trial – JAMA Pediatrics (free for a limited period)
News Release: Simple nasal spray significantly reduces snoring and breathing difficulties in children – Murdoch Childrens Research Institute
Commentary: Pediatric Sleep-Disordered Breathing Managed in Primary Care with Corticosteroid or Saline – HCP Live
Commentary on Twitter
Study suggests that in primary care, first-line treatment of sleep-disordered breathing in children could include 6 weeks of intranasal saline, or corticosteroid, which may resolve symptoms in almost one-half of children. https://t.co/oWrwcjgkPS @kirstenperrett
— JAMA Pediatrics (@JAMAPediatrics) January 17, 2023
Prescribing cascades: how to detect them, prevent them, and use them appropriately
23 Jan, 2023 | 13:41h | UTCRelated:
Evidence of a gabapentinoid and diuretic prescribing cascade among older adults with lower back pain – Journal of the American Geriatrics Society (link to abstract – $ for full-text)
Are you the victim of a prescribing cascade?
Prescribing Cascade in a Cardiology Practice
Perspective | The next generation of evidence-based medicine
23 Jan, 2023 | 13:37h | UTCThe next generation of evidence-based medicine – Nature Medicine
Commentary: What does the future of clinical trials and evidence-based medicine look like? – News Medical
Commentary on Twitter
Technological advances are transforming evidence generation in medicine. For these advances to impact public health, the clinical trial landscape must evolve and adapt to keep pace, a Perspective in @NatureMedicine argues. https://t.co/5qwE1de26c pic.twitter.com/6RkJSmXXaC
— Nature Portfolio (@NaturePortfolio) January 21, 2023
Cohort Study | Prevalence of colorectal neoplasia 10 or more years after a negative screening colonoscopy in 120 000 repeated screening colonoscopies
23 Jan, 2023 | 13:36h | UTCCommentaries:
Prevalence of Colorectal Cancers Low 10 Years Following Negative Screening Test – HCP Live
Risk for Advanced Neoplasm Low 10+ Years After Negative Colonoscopy – HealthDay
Commentary on Twitter
Large registry-based study finds strong potential for risk-adapted #colorectalcancer screening, suggests extension of screening endoscopy intervals beyond 10 years may be warranted particularly in asymptomatic female and younger participants. https://t.co/fChg6DRyPw @DKFZ
— JAMA Internal Medicine (@JAMAInternalMed) January 17, 2023
Brief review and algorithm | Management of latent tuberculosis infection
23 Jan, 2023 | 13:35h | UTCManagement of Latent Tuberculosis Infection – JAMA (free for a limited period)
An updated “norepinephrine equivalent” score in intensive care as a marker of shock severity
23 Jan, 2023 | 13:34h | UTC
Guideline | Management of metastatic castration-naive and castration-sensitive prostate cancer
23 Jan, 2023 | 13:33h | UTC2022 UPDATE: Canadian Urological Association-Canadian Urologic Oncology Group guideline: Metastatic castration-naive and castration-sensitive prostate cancer – Canadian Urological Association Journal (PDF here)
See also: Summary of changes (PDF here)
Clinical challenges in pediatric ventilation liberation: a meta-narrative review
23 Jan, 2023 | 13:31h | UTC
Non-oncogene addicted metastatic non-small-cell lung cancer: ESMO Guideline for diagnosis, treatment and follow-up
23 Jan, 2023 | 13:32h | UTC
M-A | High-flow oxygen and other noninvasive respiratory support therapies in bronchiolitis
23 Jan, 2023 | 13:28h | UTC
M-A | Noninvasive ventilation for acute respiratory failure in pediatric patients
23 Jan, 2023 | 13:30h | UTCNoninvasive Ventilation for Acute Respiratory Failure in Pediatric Patients: A Systematic Review and Meta-Analysis – Pediatric Critical Care Medicine (free for a limited period)
SR | Mortality as a measure of treatment effect in clinical trials recruiting critically ill patients
23 Jan, 2023 | 13:27h | UTCMortality As a Measure of Treatment Effect in Clinical Trials Recruiting Critically Ill Patients – Critical Care Medicine (free for a limited period)
RCT | Adjuvant S-1 compared with observation in resected biliary tract cancer
23 Jan, 2023 | 13:24h | UTCAdjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
New @TheLancet – Nakachi et al – Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial https://t.co/E6y7a9dWNf#gitwitter #biliarytractcancer #onctwitter @OncoAlert #JCOG pic.twitter.com/WEBFXjIWce
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) January 20, 2023
Review | Wellens syndrome: an important consideration in patients with chest pain
23 Jan, 2023 | 13:26h | UTCWellens syndrome: An important consideration in patients with chest pain – JAAPA
Commentary: Wellens Syndrome Important to Consider if Chest Pain: Key Points – American College of Cardiology
RCT | Small study suggests hybrid ablation is more effective than repeated catheter ablation in persistent atrial fibrillation
23 Jan, 2023 | 13:23h | UTC
RCT | Cognitive-behavioral therapy reduces psychological distress in younger patients with cardiac disease
23 Jan, 2023 | 13:23h | UTCCognitive-behavioural therapy reduces psychological distress in younger patients with cardiac disease: a randomized trial – European Heart Journal (free for a limited period)
News Release: Talking therapies reduce anxiety and depression in working age heart patients – European Society of Cardiology
Commentary on Twitter
Relevant effect on anxiety and depression of brief cognitive-behavioural therapy delivered by cardiac nurses to cardiac patients!https://t.co/XxmTs4OGyI#distress #therapy #cardiac #rehabilitation #cardiotwitter #ehj @ESC_Journals @escardio @BFHCardio pic.twitter.com/iUTejSIjqD
— EHJ Editor-in-Chief (@ehj_ed) January 20, 2023
Single-arm phase 2 study | Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma
23 Jan, 2023 | 13:22h | UTCFutibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
FGFR2 fusions or rearrangements occur in up to 14% of patients with intrahepatic cholangiocarcinoma. In a study, futibatinib, an FGFR inhibitor, induced responses (median, 9.7 months) in 42% of patients. https://t.co/FAXE2AnQ90 pic.twitter.com/9Fn9KxZxeg
— NEJM (@NEJM) January 19, 2023
Cohort Study | Hemicolectomy vs. appendectomy for patients with appendiceal neuroendocrine tumors 1–2 cm in size
23 Jan, 2023 | 13:21h | UTCHemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study – The Lancet Oncology (link to abstract – $ for full-text)
Commentary: Appendectomy With or Without Hemicolectomy for 1- to 2-cm Appendiceal Neuroendocrine Tumors – The ASCO Post
M-A | Routine use of α1-antagonists in orthopedic surgery increases adverse events and does not reduce postoperative urinary retention
23 Jan, 2023 | 13:20h | UTC
Commentary on Twitter
#ICYMI
Do α1-antagonists prevent retention after #ortho #surgery?#systematicreview and meta-analysis says no, and high rates of α related complications seencaveat – few trials!https://t.co/kTaK5Oej85#some4surgery @asgbi @SEIQuirurgica pic.twitter.com/amMrVRGhbf
— BJS Open (@BjsOpen) January 19, 2023
Review | Cardiovascular outcomes in type 1 and type 2 diabetes
23 Jan, 2023 | 13:18h | UTCCardiovascular outcomes in type 1 and type 2 diabetes – Diabetologia
Commentary on Twitter
Useful review of Cardiovascular outcomes in type 1 and type 2 diabeteshttps://t.co/mDECkFbZCq pic.twitter.com/q7J74FkNgJ
— Prof Kamlesh Khunti (@kamleshkhunti) January 20, 2023
Article under a http://creativecommons.org/licenses/by/4.0/. License
M-A of Observational Studies | Physical activity and risk of major diabetes-related complications in individuals with diabetes
23 Jan, 2023 | 13:17h | UTC
Commentary on Twitter
Dose-response meta-analysis on physical activity and diabetes-related complications in prospective studies. Even at low levels, physical activity was associated with lower relative risk of complications. @DiabResearch
Read Here➡️https://t.co/x0ElyfWEDH pic.twitter.com/tcLRIsLExP
— Diabetes Care, a research journal of the ADA 🌟 (@DiabetesCareADA) December 7, 2022